Predicted protein targets (top 2)
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL16627313 | 0.97 | HPRT1 (0.70) | HPRT1PNP | |
| SCHEMBL16627324 | 0.92 | HPRT1 (0.74) | HPRT1PNP | |
| SCHEMBL16625385 | 0.92 | HPRT1 (0.74) | HPRT1PNP | |
| SCHEMBL16625418 | 0.92 | HPRT1 (0.64) | HPRT1PNP | |
| SCHEMBL16627323 | 0.91 | HPRT1 (0.69) | HPRT1PNP | |
| SCHEMBL16625392 | 0.90 | HPRT1 (0.74) | HPRT1PNP | |
| SCHEMBL16625396 | 0.90 | HPRT1 (0.63) | HPRT1PNP | |
| SCHEMBL16625401 | 0.90 | HPRT1 (0.75) | HPRT1PNP | |
| SCHEMBL16627322 | 0.89 | HPRT1 (0.68) | HPRT1 | |
| SCHEMBL16625387 | 0.88 | HPRT1 (0.59) | HPRT1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-9200020-B2 | 6-oxopurine phosphoribosyltransferase inhibitors | THE UNIVERSITY OF QUEENSLAND (AU) | 2015-12-01 | — | — | US | disclosed |
| US-20150099722-A1 | 6-OXOPURINE PHOSPHORIBOSYLTRANSFERASE INHIBITORS | THE UNIVERSITY OF QUEENSLAND (AU) | 2015-04-09 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20150099722-A1 | 6-OXOPURINE PHOSPHORIBOSYLTRANSFERASE INHIBITORS | HPRT1, APRT, TPMT | HPRT1 1/4885PNP 11/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.